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Interactions amongst genes, known as epistasis, are
assumed to make a substantial contribution to the
genetic variation in infectious disease susceptibility,
but this claim is controversial. Here, we focus on the
debate surrounding the evolutionary importance of
interactions between resistance loci and argue that its
role in explaining overall variance in disease outcomes
may have been overestimated.The genetic architecture of complex traits
A quantitative genetic understanding of complex traits isOpinion
Differences amongst individuals in their susceptibility to
infection seldom have a simple genetic basis and are
often determined by a complex interplay of multiple loci.
Characterizing the number, location and effect size of
the quantitative trait loci (QTL) underlying this variation
informs our understanding of not only the pathways that
influence susceptibility, but also the potential coevo-
lutionary dynamics of host and parasites. Of particular
interest is the role that epistasis, defined broadly as in-
teractions among loci in determining a phenotype, has
in shaping the variation we see in infectious disease sus-
ceptibility. For most complex traits, quantitative genetic
theory suggests that epistasis is unlikely to contribute
substantially to genetic variation [1,2]. However, models
of host-parasite co-evolution typically feature some de-
gree of epistasis between resistance loci [3,4], and the
results of empirical linkage and association mapping stu-
dies suggest that epistatic interactions can explain con-
siderable variation in infectious disease characteristics
within natural populations [5,6].
In this article, we will discuss the current state of
genetic studies of disease susceptibility, with a particular* Correspondence: matt.hall@unibas.ch
University of Basel, Zoological Institute, Vesalgasse 1, Basel, CH-4051,
Switzerland
© 2013 Hall and Ebert; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the orfocus on the theoretical and empirical support for
epistasis. We then ask if the genetic basis of infectious
disease susceptibility is different from other traits, or if
the evidence for epistatic interactions has been over-
estimated. To provide the necessary background, we
first give a brief overview of the debate surrounding
the contribution of epistasis to the genetic architec-
ture of complex traits.based on partitioning the variation between individuals
that is due to their genotypes into additive, dominance
and epistatic components [7]. Each component relates to
a different form of gene action, with the additive compo-
nent describing the variance associated with the inde-
pendent contribution of alleles, dominance describing
the variance contributed by interactions between alleles
at the same locus, and epistasis referring to the contri-
bution of interactions between alleles at different loci
(Figure 1). While the relative contribution of each of
these components to genetic variance depends on the
underlying allele frequencies within a population, quan-
titative genetic theory suggests that most of the genetic
variation in a population will be due to the additive ef-
fect of allelic substitutions [1]. Yet this assertion is not
without controversy. Although the additive genetic basis
of a trait can be readily estimated using information on
the relatedness of individuals (via known breeding de-
signs or pedigrees), only a fraction of this genetic varia-
tion has been linked to underlying loci in genome-wide
association studies (GWAS; [8], but see [9]). This ‘mis-
sing heritability’, as it has been termed [10], together with
the increasing knowledge of modifier genes and gene net-
works, has led to the suggestion that epistasis may make a
substantial contribution to the overall levels of genetic
variation [5] and that the contribution of additive variance
may have even been overestimated [11].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1. Models of gene action for complex traits. Phenotypic values are shown for two diploid host loci under different patterns of gene
action. (a) Additive effects at locus A and B. Each allele contributes a fixed metric value to the trait, independent of the effects of other alleles at
the same or different loci. Human height is a classic example of a complex trait where approximately 80% of the variation in height amongst
individuals is due to additive genetic effects [8]. (b) Dominance at locus A. Both loci are independent, but with dominance occurring at locus A,
as the phenotypic value of the heterozygote is not midway between the values of the two homozygotes. Complete dominance, as shown here,
is typical of Mendelian genetic disorders such as Huntington's disease where an affected individual need only inherit one copy of the mutant
allele. (c) Epistatic interactions between locus A and B. Epistasis is estimated as the deviance from the additive combination of two loci and can
take many forms, depending on whether an allele combination is more or less fit than expected. Well known examples of epistasis include the
interaction between genes in shaping coat color in mice, or the occurrence of synthetic lethality seen when mutations occur in two genes with
redundant functions [13].
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the importance of epistasis at the mechanistic level is
reflected in the patterns of phenotypic and genetic varia-
tion at the level of the population. Within an individual,
interactions between genes can result from a wide range
of molecular mechanisms and can have positive or nega-
tive effects on fitness, depending on whether the resul-
ting phenotype is greater or less than the individual
effects of the alleles [12,13]. This functional impact of
gene-gene interactions, however, is different from the
statistical contribution of epistasis to complex trait var-
iation within a population [13], because the latter de-
pends on the distribution of allele frequencies in that
population [7]. If most alleles are at extreme frequencies,
then the majority of genetic variation should still be
additive, even if there is dominance or epistasis acting at
individual loci [1]. In this case, the effect of rare alleles
that interact will be negligible as the likelihood that twoAB aB Ab ab 
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Figure 2. Genetic models of host-parasite interactions. Infection outco
and parasites with two loci and two alleles each), where R represents resist
partially resistant individuals. (a) Gene-for-gene-model. The mechanistic ba
recognition of a gene product ‘elicitor’ produced by the parasite [15,16]. Th
an avirulence allele (A or B) of the parasite. (b) Matching-allele model. In an
animal immune system [14,15], the matching-allele model assumes that a h
interacting alleles. (c) Multiplicative matching-alleles model. This model is p
not implicitly involve epistatic interactions between resistance alleles at dif
host and parasite fitness in a multiplicative fashion, leading to intermediaterare alleles are present in the same individual is very
low. Thus, from a quantitative genetic perspective, it
seems unlikely that epistatic interactions will contri-
bute substantially to phenotypic variance unless the
alleles are of major effect, and the frequencies of alleles in-
volved in epistatic interactions are intermediate.
Are complex traits resulting from host-parasite
interactions different?
How then does the genetic architecture of disease resis-
tance compare to other complex traits? Based on models of
host-pathogen coevolution, resistance is commonly pre-
dicted to involve multiple host genes and strong interac-
tions between alleles at different host loci (Figure 2).
Epistasis in the matching-allele class of models, for ex-
ample, arises because each multi-locus parasite genotype
can only infect a corresponding multi-locus host genotype
[14,15]. As natural selection favors parasites that matchParasite genotypete genotype
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mes are shown for three different interaction models (haploid hosts
ant individuals, I represents non-resistant individuals, and P represents
sis of the gene-for-gene model is that resistance by the host requires
us, a host is resistant if it contains one resistance allele that matches
architecture inspired by the self-nonself recognition systems of the
ost can resist a parasite unless the parasite matches all of its
resented as a counterpoint to the matching-allele model, as it does
ferent loci [4,29]. Instead, the number of matched alleles determines
, or partial, estimates of resistance.
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notypes become disproportionately unfit, while rarer allele
combinations now have a fitness advantage. This type of
selection, whereby the fitness of a genotype decreases as
its frequency increases, is known as negative frequency-
dependent selection. Conversely, in the gene-for-gene
model of host-pathogen interactions [16], epistasis can be
incorporated via the costs associated with maintaining mul-
tiple resistance alleles (for example, [17]). Here, the costs of
resistance either accelerate or decelerate with the number
of contributing loci [18], aiding the maintenance of poly-
morphisms in resistance genes. In both cases, epistasis facil-
itates the rapid co-evolutionary cycles that are a hallmark
of host-pathogen theory [19,20], as recombination can now
break-up unfavorable allele combinations, allowing oscilla-
tions between host and parasite genotypes under negative
frequency-dependent selection.
In support of such genetic models, studies of infectious
disease susceptibility have commonly documented three
key indicators of epistasis. Both linkage and association
mapping studies have shown that variation in measures of
resistance are often associated with multiple QTL of major
effect, that interactions between loci contribute substan-
tially to phenotypic variation, and that evidence for specific
candidate loci is often difficult to replicate in other experi-
ments or environments [6,21]. In a meta-analysis of over
500 QTL mapping experiments, for example, Wilfert and
Schmid-Hempel [6] found that epistatic interactions were
identified in 48 of 62 studies involving genome-wide scans,
with most epistatic loci not previously identified using sin-
gle QTL analyses (123 of 170 loci). Conventional quantita-
tive genetic studies have also characterized the contribution
of non-additive genetic components to patterns of suscepti-
bility and resistance. Using reciprocal crosses between four
populations, for example, a study of resistance in the red
flour beetle (Triboliumcastanaeum) found that epistasis
explained significant variation in host survival only upon
infection by a parasite, and not under the unexposed and
uninfected control conditions [22].
Has the evidence for epistasis been
overestimated?
At first glance, the high prevalence of epistasis in mapping
studies of disease traits suggests that interactions amongst
host resistance genes might indeed contribute substantially
to variation in disease susceptibility, as is assumed by
models of host-parasite coevolution. What needs to be
taken into account, however, is the estimation bias inherent
in conventional mapping studies. Minor effect variants, for
example, are unlikely to be identified in linkage studies
due to a combination of broadly spaced markers and lim-
ited sample sizes. Conversely in association mapping,
rare alleles will be difficult to detect due to the reliance on
linkage disequilibrium between common markers andcommon causative variants (see discussions in [23]). Gene
frequencies are also altered as part of the design of trad-
itional mapping panels, which typically involve some level
of inbreeding, combined with crosses between a few indi-
viduals representing phenotypic or even population ex-
tremes. In an F2 inter-cross between high and low
resistance genotypes, for example, allele frequencies are
on average 0.5, even if variants within the mapping panel
were at extreme frequencies in the original population.
Thus, by concentrating or combining alleles of major ef-
fect within and between populations, conventional map-
ping studies bias allele frequencies towards intermediate
values and therefore increase the chance of finding
epistasis.
Without information on the effect size and frequency of
alleles in natural populations, it is difficult to determine
whether epistatic interactions contribute substantially to
genetic variation in quantitative susceptibility, or if the con-
tribution of such interactions to individual variation has
been overestimated. The lack of success in identifying the
same loci across different experiments, for example, could
be due to epistasis between resistance loci, or the result of
the strong sampling bias and small fraction of genetic vari-
ation that is captured using experimental crosses. Nonethe-
less, identified epistatic interactions can be functionally
important. In a number of studies, gene-gene interactions
have helped characterize the pathways underlying the
mechanisms of resistance (for example, [24-27]). In the
mouse, for example, epistatic interactions revealed a new
mechanism for resistance to the mouse cytomegalovirus,
which involves an interaction between a receptor for nat-
ural killer cells and a molecule of the major histocompati-
bility complex on virus-infected cells [28]. Such studies
highlight the functional utility of characterizing epistasis,
even if the statistical contribution of each gene-gene inter-
action to variation in a complex trait remains unclear.
Reconciling quantitative genetic and host-parasite
theory
While epistasis is an integral component of many models
of disease resistance and antagonistic coevolution (but not
all [4,29]; Figure 2), the contribution of epistatic variance to
susceptibility remains difficult to evaluate using conven-
tional QTL mapping methods. With the advent of next
generation sequencing approaches, however, new insights
can be generated into the genetic architecture of suscepti-
bility [23,30]. GWAS, for example, allow for the total gen-
etic variation within a population to be decomposed into
the combined effect of all loci acting additively (for ex-
ample, [9]). The remaining, unexplained genetic variation,
therefore, gives an upper limit for how much epistasis could
potentially contribute to variation in infectious disease [1].
Observed allele frequencies and effect-size parameters can
also be estimated for a range of susceptibility loci (sensu
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lele frequencies predicted by different models of host-
parasite coevolution. Yet, higher marker densities and
GWAS do not completely resolve the contribution of spe-
cific gene-gene interactions to trait variation. Pairwise epi-
static interactions are difficult to evaluate using the
hundreds or thousands of makers required for conventional
QTL mapping studies, let alone using the millions of
markers required for GWAS.
Even in model systems where next generation sequencing
approaches have been used extensively, we are far from a
general understanding of the underlying architecture of re-
sistance and susceptibility. In Drosophila, for example, con-
siderable progress has been made in identifying loci
underlying resistance to sigma virus transmission and veri-
fying the importance of the resistance alleles in natural pop-
ulations [32-35]. Yet resistance genes, such as ref(2)P, are
often strain specific and do not completely account for the
genetic variance underlying resistance to multiple virus iso-
lates [36]. Similarly, despite the wide range of infectious dis-
eases that have been studied in humans using high-density
genetic maps [37,38], debate is still ongoing as to the distri-
bution of allelic variants, and whether the genetic basis of
susceptibility is based on high frequency common variants
or the cumulative effects of many rare mutations [30]. As
such, we suggest that two key aspects of host-parasite biol-
ogy will need more consideration as we move forward in
the genomics era: first, that our understanding of the genet-
ics of susceptibility will depend on the number of parasite
genotypes included in association studies; and second, that
the expectation of epistasis may not be appropriate for all
measures of resistance.
How we account for the natural genetic diversity of para-
sites will strongly influence our understanding of the gen-
etic architecture of susceptibility. If the causal parasite is
unknown or resistance is assessed using a mix of parasite
genotypes, then mechanisms unrelated to resistance could
be contributing to variation in infectious disease. Competi-
tion between multiple parasite genotypes within the host
[39,40] and variation in dose-dependent effects across iso-
lates [41] are all processes that would bias infection esti-
mates. Conversely, if only a single pathogen genotype is
used in a mapping study, then the relevance of any candi-
date loci is difficult to extend beyond the response of the
host to that specific genotype. Indeed, where multiple
strains of a parasite have been utilized within a mapping or
association study, the results suggest that only a subset of
identified QTL will confer resistance to all genotypes [6]. A
study exploring the association between mosquito immune
genes and infection by Plasmodium falciparum, for ex-
ample, revealed that certain candidate loci explained pat-
terns of resistance only for specific parasite isolates [42].
These findings highlight the need to account for the contri-
bution of parasite genetic variation to variation in hostsusceptibility, otherwise the genetic architecture of disease
susceptibility will be misrepresented.
Careful consideration of the trait used to characterize
resistance will also be important for mapping studies.
Phenotypes of resistance range from infection rates and
parasite loads, through to symptoms of disease such as
morbidity and mortality. Underlying each of these mea-
sures will be a range of processes involving the ability of
a pathogen to penetrate the host, the recognition of
parasite proteins by the host, and the subsequent im-
mune response facilitating pathogen replication [43,44].
Thus, the type of trait used to estimate resistance and
the timing of a phenotypic assay (early or late in the
infection process) could significantly influence the
characterization of phenotypic and genetic variance. Es-
timating resistance based on symptoms of disease, for
example, may more closely match classical quantitative
genetic theory, whereas the initial ability of a parasite to
penetrate a cell or tissue is a better fit for models of host
resistance where epistasis features strongly. Indeed, ini-
tial infectivity in plants is often highly specific to certain
host-parasite combinations, suggesting that suscepti-
bility/resistance may be under control of a few major
genes [45]. Although such insights are uncommon in
animals, studies are beginning to reveal that initial re-
sistance to certain pathogens may follow a similar pat-
tern [46], with subsequent symptoms of disease being
more quantitative [47].
In summary, the contribution of epistasis to pheno-
typic and genetic variation is a complex issue for studies
of host-parasite interactions. Unlike other quantitative
traits, where theory points to the largely additive contri-
bution to genetic variation [1], epistasis is a key compo-
nent of many models of host-parasite interactions. As
such, host-parasite research has focused on characteriz-
ing epistasis between resistance loci, rather than debat-
ing and evaluating the relative contributions of additive
and epistatic genetic effects to phenotypic variance.
Nonetheless, as more studies characterize the allelic var-
iants underlying quantitative susceptibility in natural
populations, the opportunity to reassess the importance
of epistasis will help redefine how empirical and theoret-
ical research approaches the genetic architecture of
host-parasite interactions.
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